These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7449527)
1. [Immunotherapy of Friend leukemia with antiserum (author's transl)]. Lynn TC; Metzgar RS Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):94-104. PubMed ID: 7449527 [TBL] [Abstract][Full Text] [Related]
2. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice. Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes. Pettey CL; Collins JJ Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757 [TBL] [Abstract][Full Text] [Related]
4. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy. Genovesi EV; Pettey CL; Collins JJ Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of murine leukemia. VII. Prevention of Friend leukemia virus-induced immunosuppression by passive serum therapy. Genovesi EV; Livnat D; Collins JJ Int J Cancer; 1982 Nov; 30(5):609-24. PubMed ID: 6984021 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against Friend leukemia virus-induced disease by passive serum therapy. Genovesi EV; Livnat D; Collins JJ Leuk Res; 1982; 6(4):577-93. PubMed ID: 6958931 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease. Collins JJ; Sackie DM; Johnson GR Virology; 1983 Apr; 126(1):259-66. PubMed ID: 6573816 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections. Genovesi EV; Marx PA; Wheelock EF J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy. Sanfilippo F; Genovesi EV; Collins JJ J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369 [TBL] [Abstract][Full Text] [Related]
10. Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease. Collins JJ; Snyderman R Cancer Res; 1980 Mar; 40(3):557-62. PubMed ID: 6258783 [TBL] [Abstract][Full Text] [Related]
11. [Protection of mice against Friend leukemia by active and passive immunization with isolated viral glycoprotein and its antiserum respectively (author's transl)]. Hunsmann G; Moennig V; Seifert E; Schäfer W Z Naturforsch C Biosci; 1975; 30(2):309-10. PubMed ID: 125981 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection. Kitagawa M; Kamisaku H; Aizawa S; Sado T Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008 [TBL] [Abstract][Full Text] [Related]
13. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. Metzgar RS; Mohanakumar T; Bolognesi DP J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269 [TBL] [Abstract][Full Text] [Related]
14. Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia. Wirth JJ; Levy MH; Wheelock EF J Immunol; 1976 Dec; 117(6):2124-30. PubMed ID: 186537 [TBL] [Abstract][Full Text] [Related]
15. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia. Kitagawa M; Matsubara O; Kasuga T Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802 [TBL] [Abstract][Full Text] [Related]
16. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus. Genovesi EV; Collins JJ J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299 [TBL] [Abstract][Full Text] [Related]
17. Effects of Friend leukemia virus (FLV) inoculation in F1 mice and differentiation of FLV-induced leukemia. Kitagawa M; Matsubara O; Kasuga T Histol Histopathol; 1986 Oct; 1(4):335-40. PubMed ID: 2980128 [TBL] [Abstract][Full Text] [Related]
18. Immunofluorescence study of thymuses of mice given Friend leukemia virus: conventional vs monoclonal antibodies. Ranucci A; Accinni L; Del Gobbo V; Titti F; Fiorucci G; Manzari V; Premrov MG; Tonietti G Microbiologica; 1985 Jan; 8(1):1-9. PubMed ID: 3883101 [TBL] [Abstract][Full Text] [Related]
19. Lymphocyte surface receptors and leukemia virus-induced immunosuppression. Friedman H; Kateley JR Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386 [TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of antiviral resistance by lymphoid cells from mice protected against Friend leukemia virus-induced disease by passive serum therapy. Collins JJ; Genovesi EV; Livnat D; Sanfilippo F Cancer Res; 1981 Jun; 41(6):2407-15. PubMed ID: 7016314 [No Abstract] [Full Text] [Related] [Next] [New Search]